Journal: NA | PMID: 33046353 | doi: S1138-3593(20)30288-4-10.1016/j.semerg.2020.07.007 | Type: English Abstract-Practice Guideline. The new coronavirus (SARS-CoV-2) is responsible for a severe acute respiratory syndrome. Among its manifestations, it ca (...)
Journal: NA | PMID: 33046686 | doi: 10.12659/AJCR.925932 | Type: Journal Article. BACKGROUND Coronavirus disease 2019 (COVID-19) is a newly emerging disease that is still not fully characterized. It is (...)
Journal: NA | PMID: 33049563 | doi: S0956-5663(20)30692-8-10.1016/j.bios.2020.112703 | Type: Journal Article. COVID-19 pandemic has affected everyone throughout the world and has resulted in the loss of lives of many souls. Due to (...)
Journal: NA | PMID: 33048300 | doi: 10.1007/s40259-020-00448-5 | Type: Journal Article. Itolizumab is a first-in-class anti-CD6 monoclonal antibody that was initially developed for various cancers and was lat (...)
Journal: NA | PMID: 33046293 | doi: S0735-6757(20)30791-9-10.1016/j.ajem.2020.08.097 | Type: Journal Article-Review. The ongoing pandemic of COVID-19 brought to the fore prone positioning as treatment for patients with acute respiratory (...)
Journal: NA | PMID: 33046370 | doi: S1076-6332(20)30543-2-10.1016/j.acra.2020.09.004 | Type: Journal Article. This study was to investigate the CT quantification of COVID-19 pneumonia and its impacts on the assessment of disease s (...)
Journal: NA | PMID: 33048028 | doi: 10.1080/07315724.2020.1826005 | Type: Journal Article. As effective medication to treat COVID-19 is currently unavailable, preventive remedies may be particularly important. T (...)
Journal: NA | PMID: 33047848 | doi: 10.1111/bcp.14598 | Type: Journal Article-Review. To assess whether randomized clinical trials (RCTs) proposed to evaluate the treatment of patients with COVID-19 with hy (...)